^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    HDP-103

    i
    Associations
    News
    Trials
    Company:
    Heidelberg Pharma, Huadong Medicine
    Drug class:
    PSMA-targeted antibody-drug conjugate, RNA polymerase 2 inhibitor
    Related drugs:
    Associations
    News
    Trials